SUTRO BIOPHARMA INC (STRO) Stock Income Statement
NASDAQ:STRO - Nasdaq - US8693671021 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 62.04M | 153.73M | 67.77M | 61.88M | 42.72M | |||
| Operating Expenses | 300.50M | 243.01M | 196.72M | 160.40M | 113.78M | |||
| Research and Development | 252.04M | 180.43M | 137.17M | 104.40M | 76.96M | |||
| Selling, General, and Administrative Expenses | 48.45M | 62.58M | 59.54M | 56.00M | 36.82M | |||
| Operating Income | -238.45M | -89.28M | -128.94M | -98.52M | -71.06M | |||
| Interest Income/Expense | 44.42M | 13.25M | 12.24M | -7.01M | 38.93M | |||
| Other Income/Expense | -31.07M | -12.57M | N/A | N/A | N/A | |||
| Income Before Taxes | -225.10M | -88.60M | -116.70M | -105.54M | -32.13M | |||
| Income Tax | 2.36M | 18.19M | 2.50M | N/A | N/A | |||
| Net Income | -227.46M | -106.79M | -119.20M | -105.54M | -32.13M | |||
| EBITDA | -231.24M | -82.46M | -123.25M | -93.68M | -66.76M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.96 | -1.78 | -2.35 | -2.29 | -0.99 | |||
| Non GAAP EPS | -3.02 | -1.78 | -2.44 | -2.29 | -2.46 | |||
| Statistics | ||||||||
| Profit Margin | -366.62% | -69.47% | -175.89% | -170.56% | -75.21% | |||
| Operating Profit Margin | -384.34% | -58.07% | -190.26% | -159.21% | -166.34% | |||
All data in USD